Nel (NEL) Q4 2018 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2018 earnings summary
17 Oct, 2026Executive summary
Q4'18 revenue was NOK 124.9 million, up 8% YoY; reported EBITDA was NOK -41.9 million, including NOK 23.6 million of non-recurring and ramp-up costs.
Order backlog was ~NOK 350 million, excluding commercial station orders from Nikola; the sales pipeline reached an all-time high.
Growth initiatives, heavy-duty vehicle opportunities and major project tenders were priorities, with management cautioning that near-term EBITDA would be pressured.
Financial highlights
Q4'18 revenue was NOK 124.9 million versus NOK 115.6 million in Q4'17; FY'18 revenue was NOK 489.1 million versus NOK 302.2 million in FY'17.
Q4'18 EBITDA was NOK -41.9 million reported and NOK -18.3 million adjusted; Q4'17 EBITDA was NOK -23.9 million.
Q4'18 EBIT was NOK -60.7 million reported and NOK -37.1 million adjusted; FY'18 EBIT was NOK -196.1 million versus NOK -117.2 million in FY'17.
Q4'18 net loss was NOK 54.5 million reported and NOK 30.9 million adjusted; FY'18 net loss was NOK 189.0 million versus NOK 52.4 million in FY'17.
Q4'18 operating cash flow was NOK -44.6 million versus NOK 2.7 million in Q4'17; FY'18 was NOK -142.6 million versus NOK -113.0 million in FY'17.
Outlook and guidance
Ongoing growth initiatives and focus on long-term, high-value orders were expected to weigh on the ability to deliver positive EBITDA in the short term.
Work continued on the planned 10x Notodden factory expansion to support deliveries to Nikola and other customers; expansion timing would align with commercial demand.
Priorities included heavy-duty fueling, next-generation electrolyzers for industrial uses, China market penetration and the H2Bus Europe rollout.
Larger electrolyzer and H2Station tenders remained active, with the pipeline continuing to strengthen.
Latest events from Nel
- Record backlog and mega-scale hydrogen projects put capacity expansion in focus.NEL
Q4 2017 - Q4 revenue rose as hydrogen contracts and renewable projects expanded.NEL
Q4 2016 - Order intake surged as revenue fell, Alkaline weakened and HYDS projects remained at risk.NEL
Q3 2026 - Order intake soared 224% as new technology launched, despite revenue and EBITDA declines.NEL
Q2 2026 - Revenue and orders fell, but EBITDA loss narrowed and new technology launches are underway.NEL
Q1 2026 - Order intake surged and new tech launch is set for 2026 despite heavy impairments and losses.NEL
Q4 2025 - Revenue down 10%, net loss narrowed, and major strategic deals followed Cavendish spin-off.NEL
Q2 2024 - Revenue fell 44% but record PEM order intake and cost cuts support strong cash reserves.NEL
Q1 2025 - Q4 2024 saw improved EBITDA, strong cash, and tech advances amid order and backlog shifts.NEL
Q4 2024